The aim of this study was to assess the bioequivalence of H 13 CO -3 and H 14 CO -3 , by administering both labels simultaneously by single infusion and comparing their recovery in breath CO 2 and urinary urea. Six healthy male subjects (age range 24±41 years; weight 76×7 (SD, 18×6) kg; height 1×79 (SD 0×05) m) were infused with unprimed solutions of HCO 3
3 , by administering both labels simultaneously by single infusion and comparing their recovery in breath CO 2 and urinary urea. Six healthy male subjects (age range 24±41 years; weight 76×7 (SD, 18×6) kg; height 1×79 (SD 0×05) m) were infused with unprimed solutions of HCO 3
-(110×0 mmol/kg) labelled with 13 C (0×76 mmol 13 C/h) and 14 C (48 Bq/h) at a constant rate for 6 h, in a whole-body calorimeter (1400 litres) for measurement of CO 2 production. Samples of breath were collected hourly in a Douglas bag and all urine was collected into two batches (0±4 h and 4±6 h) for estimating recovery of infused label by measurement of enrichment or speci®c activity. Recovery in breath CO 2 of both labels increased from about 25 % for the ®rst hour to 88 % and above for hours 3±4 onwards. Mean recovery of 13 C in breath CO 2 was slightly higher than that of 14 C for all periods (mean difference always less than 1 % of infused label) but was signi®cant only for the ®rst 3 h (P , 0×05). Recovery of 14 C in urea was signi®cantly higher (P , 0×01) than 13 C, but was confounded by substantial variability and uncertainties concerning 13 CO 2 background enrichments. These results suggest that there is no compelling need to alter factors currently used for recovery of 14 C in breath when using 13 C instead, and vice versa.
Carbon isotopes: Bioequivalence: Bicarbonate: Recovery factors
The recovery in breath CO 2 of labelled HCO 3 -is of major importance to metabolic studies involving oxidation of Clabelled substrates, including amino acids (James et al. 1976; Beaufrere et al. 1989) , fats (Issekutz et al. 1968) and carbohydrates (Saris et al. 1993; Leijssen et al. 1995) , and to the assessment of energy expenditure using the bicarbonate ) and bicarbonate-urea (Elia et al. 1995) methods. The choice of values appropriate for these studies for the recovery of bicarbonate in breath, depends on biological factors that lead to the incomplete recovery of label, including accumulation in the CO 2 pools of the body, especially those that have a slow turnover, and metabolic ®xation into other substrates (e.g. urea) or possible recycling of tracer (Pacy et al. 1989) . However, the situation is complex because additional label from C-labelled substrates is incorporated into citric acid and other intermediates which are linked to, or exchange label with, other pathways. Therefore, the recovery of labelled acetate may be lower than that of HCO 3 -. The acetate correction factor (fractional recovery of labelled CO 2 after infusion of acetate; Schrauwen et al. 1998) may be in¯uenced by the type of labelling used (acetate labelled at C-2 results in very different correction factors from that labelled at C-1; Wolfe & Jahoor, 1990), exercise and rest (Sidossis et al. 1995) , and the fed and fasted states (anticipated variation of¯ux of acetate into lipogenic substrates). It also depends on the length of infusion, which so far has been only a few hours (Wolfe & Jahoor, 1990; Sidossis et al. 1995) . The acetate correction factor also assumes (with little direct evidence) that the tissues utilise labelled substrates and acetate in the same proportions. This would account for different fates of acetate through either the lipogenic or gluconeogenic pathways. For example, labelled citric-acid cycle intermediates can be shunted to glucose in some tissues (e.g. liver) but not others (e.g. muscle or adipose tissue which lack gluconeogenic pathways). Finally, the HCO 3 -correction factor is more appropriate than the acetate correction factor in the HCO 3 -±urea method for estimating energy expenditure through the measurement of isotopic dilution of CO 2 (Elia et al. , 1995 Leijssen & Elia, 1996) . Although this variability may be attributable to inconsistencies in methodology between studies, it may also originate from differences in biological behaviour (bioequivalence) between H 13 CO -3 and H 14 CO -3 , which are consistent with generally lower recoveries of 13 C than 14 C observed in breath CO 2 in studies involving either bolus administration (68×7 % v. 84×3 % in 194 and 13 subjects respectively) or constant infusion of label (81×7 % v. 87×1 % in 156 and 131 subjects respectively) (Leijssen & Elia, 1996 (Klein, 1991) . In plants, discrimination can also occur during photosynthesis. Those with the C 3 pathway, such as wheat and rice, discriminate against ®xation of atmospheric 13 CO 2 by the action of ribulose 1,5-bisphosphate carboxylase producing grain with a typical depletion of -27 ½ relative to the International limestone standard Pee Dee Belemnite (PDB). In contrast, plants with the C 4 pathway, such as maize and sugar cane, produce grain with a typical value of -11½ relative to PDB (O'Leary, 1981; Farquhar et al. 1989) . Preferential ingestion of either C 3 -(e.g. wheat, rice, sugar beet and potatoes) or C 4 -(maize and sugar cane) derived carbohydrates may lead to relative differences in 13 CO 2 enrichment in breath, as indicated by greater enrichment due to the more usual consumption of C 4 plants in the American diet compared to the staple C 3 plants in Europe (Wagenmakers et al. 1993) .
However, no studies in human subjects have compared directly the bioequivalence of H -labelled with both isotopes simultaneously, and to obtain preliminary information regarding recoveries of these isotopes in urinary urea.
Methods

Subjects
The general characteristics of the six healthy male subjects were as follows: median age 33 (range 24±41) years; mean weight 76×7 (SD 18×6) kg; height 1×79 (SD 0×05) m; BMI 24×0 (SD 5×6) kg/m 2 . Subjects were studied after an overnight fast, although during infusions the drinking of water was encouraged to promote urine production. C-radioactivity (6 Bq/g solution). To ensure consistency between infusions and absolute accuracy, the total amount of solution infused was determined gravimetrically (change in weight of the syringe plus infusate between the beginning and end of each infusion). A constant hourly rate of infusion had been established previously by simply running the syringe pump continuously for a number of hours and collecting the delivered solution separately into pre-weighed receptacles exactly on each hour, and then re-weighing.
During the infusion, the subject was con®ned to a purpose-built portable`tent' indirect calorimeter of about 1400 litres capacity, ®tted over a bed (Crisp & Murgatroyd, 1985) in which limited movement was permitted. The difference between CO 2 concentrations of ingoing ambient air and outgoing calorimeter air, measured with an infra-red CO 2 analyser, was used to assess CO 2 production rates under conditions of standardised temperature and pressure (Elia & Livesey, 1992) .
At hourly intervals, beginning 1 h before the start of infusion, the subject collected end expiratory air in a Douglas bag of about 12 litres capacity. After emptying the bladder and discarding the urine produced overnight, all subsequent urine production was collected into the following three batches: (1) 2 h immediately before the beginning of infusion (for background measures); (2) 0±4 h of infusion; (3) 4±6 h of infusion.
Measurements
Infusate. HCO 3 -concentration of the infusate was measured in triplicate using an established colorimetric method (Fuller & Elia, 1989; . Standard reference solutions were prepared using BDH analar quality K 2 CO 3 and KHCO 3 (BDH, Merck Ltd, Poole, Dorset, UK), adjusted for percentage purity claimed by the manufacturer, or were obtained commercially (Sigma, Carbonate/Chloride standards; Sigma Diagnostics, Sigma Chemical Company, Poole, Dorset, UK). Radioactivity of the infusate (dpm/g) was measured in triplicate by weight (accurate to the nearest 0×0001 g) of a small amount of solution (nominally between 0×5 and 1 ml) in a scintillation vial (Elia et al. , 1995 . The 13 C fractional abundance (atom %) of labelled HCO 3 -in the infusate was determined by reverse isotope dilution with combustion isotope-ratio MS using a Carlo Erba 1500 Nitrogen Analyser (Carlo Erba, Milan, Italy) interfaced to a Sira 10 gas isotope-ratio MS. The mass balance equation was as follows (Spear et al. 1995) :
where n inf and n std are C (mmol) in the infusate and Na 2 CO 3 standard respectively, and f mix and f std are the 13 C fractional abundances in the diluted infusate and Na 2 CO 3 standard respectively (measured by gas isotope-ratio MS).
Breath. Speci®c activity of breath CO 2 was measured by passing the expired gas collected in the Douglas bag through an accurately weighed (nominally 3 ml) amount of hyamine±methanol trapping agent (hyamine hydroxide in methanol, nominal concentration about 560±580 mmol/kg, titrated gravimetrically against 0×2 mol/litre HCl (volumetric`analar' reagent (BDH) adjusted for density) using speci®cally designed apparatus as previously described (Elia et al. 1995) . Scintillation counting was carried out as before (Elia et al. , 1995 for calculation of speci®c activity of CO 2 . Enrichment of 13 C in breath CO 2 was measured in samples of expired gas obtained by connecting a syringe to the outlet of the Douglas bag, drawing up 11 ml and then expelling it (in total, to prevent fractionation) into an 11 ml evacuated container (Exetainers; Labco Ltd, High Wycombe, Bucks., UK). These samples were taken before and after the 14 C sampling to ensure that no fractionation had occurred.
13
C : 12 C ratios were measured for each breath sample, after cryogenic puri®cation of CO 2 , using a gas isotope-ratio MS (Sira 10; Micromass, Wythenshawe, UK), internal precision < 0×01 ½. Results were expressed as d 13 C per 10 3 relative to PDB (Craig, 1957; Schoeller et al. 1980) , where: This was then converted to atom % excess, for calculation of recoveries (Klein, 1991) . Urea. Speci®c activity and enrichment of urinary urea were determined on the same sample, by the urease method, essentially as described previously (Fuller & Elia, 1989; Elia et al. 1995) but with certain additional precautions to minimise possible fractionation effects. The urease reaction was allowed to proceed to completion but no vial containing hyamine±methanol trapping agent was present at this stage. Instead, the¯ask was isolated by a three-way luer adaptor tap connected to the side arm. Once the reaction had reached completion, the¯ask air containing the CO 2 that had been produced was released through the tap into a 1 litre Douglas bag. CO 2 -free water (degassed using a vacuum pump) was added to the¯ask via the third arm of the tap in 50 ml increments until all air had been displaced into the Douglas bag. Two 1 ml samples of gas in the Douglas bag were then collected for measurement of 13 CO 2 enrichment as described earlier. Speci®c activity of CO 2 in the Douglas bag was assessed as for breath CO 2 (see earlier). A further 1 ml sample was taken from the gas remaining in the Douglas bag for measurement of enrichment, again to ensure that fractionation due to sampling had not occurred.
Calculation of recovery
Recovery of infused label as breath CO 2 was calculated as the product of the mean speci®c activity (SA) or atom % enrichment (E) of label (corrected for background) measured in samples taken at the beginning and at the end of each time period, and total CO 2 production for that period, relative to the amount of label infused : where suf®xes a and b indicate the beginning and end of that particular time period. The estimations were made assuming a linear change in speci®c activity or enrichment of CO 2 over that time (an assumed exponential change in speci®c activity or enrichment over the same time resulted in similar recoveries; see also . The area under the curve was used to estimate total recovery for the whole 6 h time course. Calculation of the recovery of label in urea was similar to that of breath, the difference being that the time periods (a±b) were either 0±4 h or 4±6 h:
Percentage of label recovered = (((SA a + SA b )/2) urea excreted (between a and b) ) 100/amount of label infused (between a and b) , or:
(((E a + E b )/2)´urea excreted (between a and b) ) 100/amount of label infused (between a and b) .
Statistics
Mean and standard deviation were used as the descriptive statistics. Paired t test and the Pearson correlation coef®-cient (r) were used to test for differences or associations between values. CV was estimated as the standard deviation of differences (d) between repeated measurements as a percentage of the overall mean and adjusted by Î2 to account for variability due to each individual measurement.
Ethical approval
Ethical approval for the study was obtained from the Ethical Committees of the Dunn Clinical Nutrition Centre and Addenbrooke's Hospital, Cambridge, UK. Signed informed consent was obtained from all subjects.
Results
The CV for repeated measurements was 0×7 % for radioactivity in CO 2 , 0×3 % for enrichment in CO 2 , and 1×1 % for HCO 3 -concentration and 1×0 % for speci®c activity in both samples and the infusate. Table 1 shows the CO 2 production rates for each hour of the 6 h infusion (these values comprise measured CO 2 production rates plus estimates of CO 2 collected in the Douglas bag intended for the sampling of enrichment and speci®c activity of CO 2 ). In addition, mean enrichments and speci®c activities of CO 2 for each of the hourly periods are presented in order to illustrate the increasing appearance of label in breath CO 2 over the course of the infusion.
Recovery of infused label (for both 13 C and 14 C) as breath CO 2 was found to rise rapidly due to the infusion, reaching values close to 90 % for 3±6 h (Table 2) . Inter-individual variation in recovery was small (generally about 2±5 %) at each hour (Table 2 ). The area under the time-recovery curve of 13 CO 2 in breath was slightly higher (, 1 %) than that for 14 CO 2 , but was not statistically signi®cant (Table 2) . However, recoveries of 13 CO 2 in breath were signi®cantly higher than for 14 CO 2 for the ®rst 3 h (time periods 0±1, 1±2 and 2±3 h, P , 0×05, , 0×01 and , 0×05 respectively), despite the small mean differences. From 4 h onwards, no signi®cant difference was detectable even though 13 CO 2 recovery remained higher.
The mean recovery of infused 13 C in urinary urea was 0×12 (SD 0×07) % for the period 0±4 h and 0×50 (SD 0×22) % for the 4±6 h period following the start of the infusion. The recovery of infused 14 C was signi®cantly higher (P , 0×01; paired t test) for both periods; 0×15 (SD 0×07) % and 0×54 (SD 0×22) % respectively.
Discussion
Considering the importance of CO 2 recovery to intermediary metabolism and energy expenditure and the current preference for using 13 C, it is perhaps surprising that there 272 N. J. Fuller et al. 1×19  ±  ±  0±1  626  88  234  33  2×09  3×61  1133  163  1±2  647  86  242  32  40×75  7×00  2710  310  2±3  654  100  244  37  57×58  8×38  3400  365  3±4  669  85  250  32  66×58  10×04  3777  434  4±5  673  98  251  36  70×25  10×58  3929  462  5±6  641  82  239  31  71×68  10×81  3988  479 PDB, Pee Dee Belemnite. * For details of subjects and procedures see pp. 270±271. ² Values comprise measured CO 2 production rates plus estimates of CO 2 collected in the Douglas Bag intended for the sampling of enrichment and speci®c activity of CO 2 . 
* For details of subjects and procedures see pp. 270±271. ² Mean cumulative recovery, equivalent to the recovery calculated using the area under the time±recovery curve. Elia, 1996) . This study has established for the ®rst time that there is very little difference between 13 C and 14 C recovered in breath CO 2 (overall the total recoveries for the 6 h period were not signi®cantly different, 72×2 % v. 72×8 % respectively) and, therefore, there is no real practical basis for altering recovery factors determined for 14 C in breath when using 13 C instead for energy expenditure estimation. However, these ®ndings do not suggest that the acetate correction factor is equally applicable to both isotopes when measuring substrate oxidation (see later).
HCO 3 -The consistency of results in this study was achieved by careful attention to detail in all methodological procedures. Wherever possible, the same protocol was adopted for both isotopes. For example, a single intravenous infusion of H C were obtained using the same sample of breath CO 2 or urinary urea. In addition, the same measured values of CO 2 or urea production rate were applied to the calculation of recovery for both isotopes in breath and urine respectively (see p. 271). Methodological precautions were also taken to eliminate or at least minimise the possibility of fractionation or the isotopic exchange of labelled sample CO 2 with ambient CO 2 . Therefore, the only uncertainties in methodology were apparently limited to possible errors in the measurement of HCO 3 -concentration,
13
C enrichment and 14 C radioactivity. However, certain precautions were taken to ensure that these particular measurements were as accurate and precise as possible, including that: (1) all critical measurements were obtained gravimetrically (to 0×0001 g), rather than volumetrically; (2) the concentrations of acid labile CO 2 in the HCO 3 -standards were virtually identical, whether they were prepared in house or were commercially available; and (3) appropriate corrections were applied for density of solutions where necessary (see pp. 270±271).
Although the results suggest that for practical purposes the same recovery factor can be used for both isotopes when calculating oxidation of C-labelled substrates and energy expenditure, they do not exclude the possibility that enzymic reactions may still discriminate between 13 Cand 14 C-labelled substrates (Pacy et al. 1989) to produce slightly different quantities of 13 CO 2 and 14 CO 2 . Measuring the recovery of labelled CO 2 in breath is too insensitive to be of value in assessing isotopic fractionation with respect to metabolic ®xation of CO 2 or its entry into body CO 2 pools of slow turnover. This is because only a small proportion of the isotope is retained in the body after the ®rst 3 h of infusion; for example, a small discrepancy of 1 %, nominally between 90 % and 91 %, of label recovered in breath CO 2 implies a difference of 11 % in the quantity of label retained or excreted via alternative routes. A more direct measurement of labelled CO 2 retained in body pools may be more sensitive and provide greater insight into metabolic bioequivalence of et al. 1998) . However, there is no indication from this study of the need, or otherwise, to change this particular factor.
Assessment of label in urinary urea potentially offers a simple way of obtaining such insight into metabolic ®xation of CO 2 . However, this possibility may be confounded by two related factors. First, sensitivity may be compromised as loss of label via this route accounts for only a very small fraction of the administered label compared to the proportion recovered in breath CO 2 . Second, the recovery of 14 C in urinary urea was signi®cantly greater than that of 13 C, which is in contrast with their respective recoveries in breath CO 2 . The lower recovery of 13 C in urea is consistent with its greater recovery in breath. However, there was a signi®cant difference between the background enrichment of 13 C in urinary urea and that in breath CO 2 (see p. 272). Although background enrichment of each individual was speci®cally used in the calculation of recovery of 13 C appropriately in either breath or urine (pp. 270±271), any change in background levels over the 6 h course of the study would not have been taken into account thus compromising the integrity of any comparison with 14 C. However, preliminary work undertaken in similar conditions (M Harding, unpublished results) suggested that any such change in enrichment of breath CO 2 would be small (maximum individual variability (SD) for breath CO 2 was only 0×40 d 13 C per 10 3 compared to the peak group mean change in the study subjects of 98×18 d 13 C per 10 3 at 6 h). This would have a negligible effect on recovery of 13 C in breath CO 2 and could, therefore, be safely ignored. In contrast, variability in urea background would have a greater effect on recovery of 13 C because of the relatively lower change in enrichment of urea over the 6 h study period; if it is assumed that variability for urea background is 0×89 d 13 C per 10 3 (the observed value) compared to the peak group mean change of 14×66 d 13 C per 10 3 in the 4±6 h period, recoveries of 13 C would be slightly lower than those reported here (0×11 % v. 0×12 % for the 0±4 h period and 0×47 % v. 0×50 % for the 4±6 h period) resulting in greater differences between 13 C and 14 C, but with 14 C recovery still higher than 13 C. It is of interest that the background enrichment of urea was higher than that for breath CO 2 , which is consistent with the greater recovery of 14 C than 13 C in urea, and may suggest that lighter isotopes are preferentially excreted in breath (i.e. rate of excretion, 12 C .
C . 14 C) possibly making heavier isotopes more available for use in the liver, and would explain the greater excretion of the heavier isotopes in urinary urea despite possible discrimination against them by the enzymes of the urea cycle. Alternatively, the CO 2 that is used to form urea in the liver may have a different enrichment to CO 2 in breath because the liver may oxidise fuels with different C-enrichments to the other organs of the body. Furthermore, faster turnover of the circulating CO 2 pool than that of the urea pool implies that CO 2 excreted in breath may not have been produced at the same time as that utilised in the urea cycle. Furthermore, for a near steady-state to be achieved with an unprimed infusion requires considerably longer than the 6 h of this study. Such infusions indicate that about 2 % of the administered label is excreted in urea (Fuller & Elia, 1989; Elia et al. 1995) , compared to only 0×5 % between 4±6 h observed here. Therefore, prolonged infusions that achieve higher and near steady-state enrichments and speci®c activities are indicated for use in future studies.
In summary, the results of this study suggest that, for practical purposes, the same recovery factors for 14 CO 2 can also be used for 13 CO 2 when assessing energy expenditure using the bicarbonate or bicarbonate±urea methods. However, they do not exclude the possibility of fractionation due to enzymatic discrimination within metabolic pathways, such as the urea cycle. In addition, as the possible preferential ®xation of label into the citric-acid cycle was not evaluated, no conclusion can be drawn concerning the effect of the different isotopes on the acetate correction factor for use in assessing oxidation of C-labelled substrates.
